Revenue
$68.6M
▼ 7.6% YoY
Net Income
-$438.0M
▲ 16.1% YoY
EPS
$-3.16
▲ 17.5% YoY
Cash
$232.2M
▲ 4.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
SATO VICKI L Director | Sell | Mar 2, 2026 | 21.8K | $9.50 | $207K | Form 4 ↗ |
SATO VICKI L Director | Sell | Mar 2, 2026 | 200 | $9.98 | $2K | Form 4 ↗ |
Eisner Mark EVP and Chief Medical Officer | Sell | Feb 25, 2026 | 1.9K | $9.82 | $19K | Form 4 ↗ |
de Verneuil Vanina EVP, General Counsel, Corp Sec | Sell | Feb 25, 2026 | 13.7K | $9.82 | $135K | Form 4 ↗ |
SATO VICKI L Director | Vest | Feb 24, 2026 | 42.4K | $1.49 | $63K | Form 4 ↗ |
SATO VICKI L Director | Sell | Feb 24, 2026 | 42.2K | $9.75 | $411K | Form 4 ↗ |
SATO VICKI L Director | Sell | Feb 24, 2026 | 200 | $10.26 | $2K | Form 4 ↗ |
Sabatini Brent SVP, Chief Accounting Officer | Sell | Feb 24, 2026 | 1.4K | $9.53 | $14K | Form 4 ↗ |
O'Byrne Jason EVP & Chief Financial Officer | Sell | Feb 24, 2026 | 1.6K | $9.53 | $16K | Form 4 ↗ |
Eisner Mark EVP and Chief Medical Officer | Sell | Feb 24, 2026 | 1.6K | $9.53 | $15K | Form 4 ↗ |
de Verneuil Vanina EVP, General Counsel, Corp Sec | Sell | Feb 24, 2026 | 3.1K | $9.53 | $30K | Form 4 ↗ |
De Backer Marianne Chief Executive Officer | Sell | Feb 24, 2026 | 14.8K | $9.53 | $141K | Form 4 ↗ |
Sabatini Brent SVP, Chief Accounting Officer | Sell | Feb 23, 2026 | 1.8K | $7.45 | $14K | Form 4 ↗ |
O'Byrne Jason EVP & Chief Financial Officer | Sell | Feb 23, 2026 | 2.1K | $7.45 | $16K | Form 4 ↗ |
Eisner Mark EVP and Chief Medical Officer | Sell | Feb 23, 2026 | 2.1K | $7.45 | $16K | Form 4 ↗ |
de Verneuil Vanina EVP, General Counsel, Corp Sec | Sell | Feb 23, 2026 | 4.4K | $7.45 | $33K | Form 4 ↗ |
De Backer Marianne Chief Executive Officer | Sell | Feb 23, 2026 | 19.0K | $7.45 | $142K | Form 4 ↗ |
Sabatini Brent SVP, Chief Accounting Officer | Grant | Feb 22, 2026 | 25.0K | $0.00 | $0 | Form 4 ↗ |
O'Byrne Jason EVP & Chief Financial Officer | Grant | Feb 22, 2026 | 55.0K | $0.00 | $0 | Form 4 ↗ |
Eisner Mark EVP and Chief Medical Officer | Grant | Feb 22, 2026 | 55.0K | $0.00 | $0 | Form 4 ↗ |
de Verneuil Vanina EVP, General Counsel, Corp Sec | Grant | Feb 22, 2026 | 55.0K | $0.00 | $0 | Form 4 ↗ |
De Backer Marianne Chief Executive Officer | Grant | Feb 22, 2026 | 285.0K | $0.00 | $0 | Form 4 ↗ |